nAChR-targeted RAP program (Rapport Therapeutics)

N/A

Report date: 2025/06/11 10:54:07
NME

Base Information

Drug NamenAChR-targeted RAP program (Rapport Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNicotinic receptors modulators
TargetsNicotinic receptors
Therapy Area/IndicationsHearing Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapport Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapport Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHearing Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A